Ledger.Open graph →
SEC Form D · Amendment · filed December 22, 2022

General Oncology, Inc

Offering
$7.5M
Sold
$3.2M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
BURLINGTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Gregg Goldstein · Burlington, MAExec · DirectorArnold Glazier · Burlington, MAExec · DirectorMichael D. Sigman · Burlington, MADirectorJeffrey A. Glazier · Burlington, MAExecMichael J. Petit · Burlington, MADirectorArora A. Govind · Weddington, NCDirectorJeffrey J. Teplitzky · Woodbridge, CTExec · DirectorTony A. Fusco · Weddington, NCExec · DirectorMichael O'Leary · Uniondale, NYDirectorJohn A. Mitchell · Weddington, NCExecRyan Friend · San Francisco, CAExec · DirectorVanessa J. Gilman · Grand Cayman, Cayman IslandsExecJames J. Kattan · Grand Cayman, Cayman IslandsExec · DirectorJames J. Kattan · Grand Cayman, Cayman IslandsDirectorVanessa J. Gilman · Grand Cayman, Cayman IslandsDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗